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Note 1: RAP-MS identifies known U1 snRNA interacting proteins. 
We validated the RAP-MS approach by defining the proteins that interact with two well-
characterized non-coding RNAs: (i) U1 small nuclear RNA, a core component of the 
spliceosome1 and (ii) 18S ribosomal RNA, a component of the small ribosomal subunit2. 
In the U1 purifications, we identified 9 enriched proteins, all of which are known to 
interact with the U1 snRNA. The list includes 7 of the 10 proteins that comprise the core 
U1 snRNP complex (U1-A, U1-C, U1-70K, Sm-B, Sm-D2, Sm-D3, Sm-E)3 as well as 
the Gemin5 processing factor involved in U1 snRNP biogenesis4 (Extended Data 2). 
The ninth enriched protein, SF3a1, had not previously been identified as a U1-interacting 
protein but was recently shown to interact directly with the U1 snRNA in vivo5.  
 
Note 2: Validation of the Xist interacting proteins identified by RAP-MS 
To confirm that the identified proteins reflect specific interactions with Xist, and are not 
due to background proteins or non-specific purification of other RNAs, we performed 
RAP using the same Xist probes in uninduced cells in which Xist is not expressed. 
Furthermore, to confirm that the identified interactions represent proteins that are 
crosslinked to Xist in vivo rather than interactions that form in solution, we purified Xist 
from cells that were not crosslinked (no UV light). In both cases, we identified none of 
these 10 Xist-interacting proteins, nor any other specifically enriched proteins in either of 
these control samples (Methods). Together, these results demonstrate that the identified 
proteins are direct RNA binding proteins that are covalently crosslinked with Xist in 
cells.  
To confirm that these proteins do not merely associate non-specifically with any nuclear 
long ncRNA, we compared Xist to the 45S pre-ribosomal RNA, which is of comparable 
length to Xist (~13,000 vs. ~17,000 nucleotides, respectively) (Methods, Extended Data 
2). Importantly, each of the 10 proteins that were enriched when comparing Xist to U1 
was still enriched when comparing Xist to 45S. In three cases (hnRNPC, RALY, and 
LBR) the enrichment level was only ~2-fold because these proteins had higher levels in 
the 45S purification, consistent with the fact that they are known to be present in the 
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nucleolus6. These results demonstrate that these 10 proteins associate with Xist 
specifically and not merely with any long RNA in the nucleus.  
Finally, we independently validated these interactions by testing whether we could enrich 
the Xist RNA upon immunoprecipitation of the identified proteins. To do this, we 
obtained high-quality IP-grade antibodies or epitope-tagged proteins for 8 of the 10 
proteins (Ptbp1, hnRNPC, CELF1, Myef2, Rbm15, LBR, RALY, and SHARP) and 
purified protein-RNA complexes from UV-crosslinked lysate (Methods). In all cases, we 
observed a strong enrichment for the Xist RNA relative to total input RNA levels (>4-
fold, Extended Data 3, Methods). In contrast, we did not observe similar enrichment for 
other control RNAs – including mRNAs (i.e. Oct4, Nanog, or Stat3) or lncRNAs (i.e. 
Neat1, Malat1, Tug1, or Firre) (Extended Data 3). For the remaining 2 proteins, we were 
unable to identify antibodies or generate affinity reagents that could be used to 
independently validate their interactions. In one case (SAF-A), the protein has been 
previously shown to directly interact with Xist in human cells7 – providing independent 
confirmation. For the remaining protein (hnRNPM), future work will be needed to 
provide independent confirmation of its interaction with Xist. 
 
Note 3: Xist silencing defects are not due to ES cell differentiation  
Since previous studies have shown that Xist can no longer initiate transcriptional 
silencing after a certain critical window during differentiation8, we wanted to ensure that 
the loss of Xist silencing upon knock down of SHARP, LBR, and SAF-A was not merely 
due to cellular differentiation. To address this, we performed single molecule FISH for 
Gpc4 mRNA along with immunofluorescence for Nanog, a marker of the pluripotent 
state that is rapidly lost upon differentiation9. We confirmed that knockdown of SHARP, 
LBR, or SAF-A also abolished gene silencing on the X-chromosome in Nanog-positive 
cells (Extended Data 5c). 
 
Note 4: Additional characterization of SHARP 
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Having identified a critical role for SHARP in PolII exclusion, we sought to further 
confirm the functional importance of SHARP. (i) We confirmed that SHARP is required 
for silencing additional X-chromosome genes by selecting three additional genes (Rbmx, 
Mecp2, and Smc1a) that are silenced at different times during the induction of XCI10. 
Knockdown of SHARP abolished the silencing of all 3 additional X-chromosome genes. 
In contrast, knockdown of SHARP had no impact on the expression of two X-
chromosome genes (Mid1 and Pir) that are known to escape XCI11 (Extended Data 6). 
(ii) We confirmed that SHARP similarly interacts with Xist in differentiating female ES 
cells. To do this, we purified SHARP from lysates of UV-crosslinked RA-treated female 
ES cells and identified a strong enrichment for Xist (>45-fold) but not for Neat1 or 45S 
(<1-fold) relative to levels in IgG (Methods, Extended Data 3b). (iii) We confirmed that 
SHARP, but not LBR, is similarly required for PolII exclusion in differentiating female 
ES cells. We knocked down SHARP, LBR, and several controls in female ES cells and 
induced Xist expression through RA-treatment and identified higher levels of PolII 
localization over the Xist-coated territory upon knock down of SHARP, but not the other 
proteins (Figure 3c, Extended Data 9). 
 
Note 5: Possible models for SHARP-mediated recruitment of PRC2 
While it is clear that SHARP and HDAC3 are required for the recruitment of PRC2, 
whether this is due to direct recruitment or indirect recruitment remains unclear. Previous 
studies suggest several possible mechanisms: (i) PolII exclusion has been shown to be 
sufficient to trigger PRC2 recruitment in other contexts12 and because SHARP is required 
for PolII exclusion on the X-chromosome, this might indirectly lead to PRC2 recruitment. 
(ii) Previous studies have shown that the PRC2 complex can interact with various HDAC 
complexes13 and accordingly PRC2 might be recruited directly by Xist through the 
HDAC3 complex. (iii) Chromatin compaction has been shown to be sufficient to mediate 
PRC2 recruitment14 because HDAC3 can lead to chromatin compaction this may 
indirectly lead to PRC2 recruitment. (iv) SHARP has been shown to interact in vitro with 
RbAp4815, a component of several chromatin regulatory complexes including the 
PRC216,17 and HDAC3 complexes18,19 and therefore Xist might directly recruit PRC2 
nucleolus6. These results demonstrate that these 10 proteins associate with Xist 
specifically and not merely with any long RNA in the nucleus.  
Finally, we independently validated these interactions by testing whether we could enrich 
the Xist RNA upon immunoprecipitation of the identified proteins. To do this, we 
obtained high-quality IP-grade antibodies or epitope-tagged proteins for 8 of the 10 
proteins (Ptbp1, hnRNPC, CELF1, Myef2, Rbm15, LBR, RALY, and SHARP) and 
purified protein-RNA complexes from UV-crosslinked lysate (Methods). In all cases, we 
observed a strong enrichment for the Xist RNA relative to total input RNA levels (>4-
fold, Extended Data 3, Methods). In contrast, we did not observe similar enrichment for 
other control RNAs – including mRNAs (i.e. Oct4, Nanog, or Stat3) or lncRNAs (i.e. 
Neat1, Malat1, Tug1, or Firre) (Extended Data 3). For the remaining 2 proteins, we were 
unable to identify antibodies or generate affinity reagents that could be used to 
independently validate their interactions. In one case (SAF-A), the protein has been 
previously shown to directly interact with Xist in human cells7 – providing independent 
confirmation. For the remaining protein (hnRNPM), future work will be needed to 
provide independent confirmation of its interaction with Xist. 
 
Note 3: Xist silencing defects are not due to ES cell differentiation  
Since previous studies have shown that Xist can no longer initiate transcriptional 
silencing after a certain critical window during differentiation8, we wanted to ensure that 
the loss of Xist silencing upon knock down of SHARP, LBR, and SAF-A was not merely 
due to cellular differentiation. To address this, we performed single molecule FISH for 
Gpc4 mRNA along with immunofluorescence for Nanog, a marker of the pluripotent 
state that is rapidly lost upon differentiation9. We confirmed that knockdown of SHARP, 
LBR, or SAF-A also abolished gene silencing on the X-chromosome in Nanog-positive 
cells (Extended Data 5c). 
 
Note 4: Additional characterization of SHARP 
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through an interaction between SHARP or HDAC3 and RbAp48 and the PRC2 complex. 
Future work will be needed to distinguish between these possible mechanisms. 
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Supplementary Table 1 
	  
Supplementary	  Table	  1:	  A	  list	  of	  all	  antibodies	  used	  for	  immunoprecipitation	  
experiments.	  
Protein	   Epitope	   Vendor	  	   Catalog	  #	  
RALY	   V5-­‐tagged	  
clone	  
Sigma	  	   V8137	  
LBR	   V5-­‐tagged	  
clone	  
Sigma	  	   V8137	  
hnRNPC	   V5-­‐tagged	  
clone	  
Sigma	  	   V8137	  
RBM15	   Endogenous	   Santa	  Cruz	  	   sc-­‐366873	  
PTBP1	   Endogenous	   Abcam	  	   ab5642	  
CELF1	   Endogenous	   Abcam	  	   ab129115	  
PUM1	   Endogenous	   Santa	  Cruz	  	   sc-­‐135049	  
MYEF2	   Endogenous	   Santa	  Cruz	   sc-­‐102031	  
hnRNPH	   Endogenous	   Bethyl	  	   A300-­‐511A	  
IgG	   None	   Cell	  
Signaling	  	  
2729S	  
SHARP	   Endogenous	   Novus	   NBP1-­‐82952	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Supplementary Table 2 
Supplementary	  Table	  2:	  A	  list	  of	  all	  siRNAs	  used	  for	  knockdown	  experiments.	  	  
Description	   Company	   Catalog	  number	  
SMARTpool:	  ON-­‐TARGETplus	  Hnrnpc	  siRNA	   Dharmacon	   L-­‐044147-­‐01-­‐0005	  
SMARTpool:	  ON-­‐TARGETplus	  Ncor2	  siRNA	   Dharmacon	   L-­‐044147-­‐01-­‐0005	  
SMARTpool:	  ON-­‐TARGETplus	  Hdac3	  siRNA	   Dharmacon	   L-­‐043553-­‐02-­‐0005	  
SMARTpool:	  ON-­‐TARGETplus	  Spen	  siRNA	   Dharmacon	   L-­‐062019-­‐01-­‐	  0005	  
SMARTpool:	  ON-­‐TARGETplus	  Rbm15	  siRNA	   Dharmacon	   L-­‐048728-­‐01-­‐	  0005	  
SMARTpool:	  ON-­‐TARGETplus	  Lbr	  siRNA	   Dharmacon	   L-­‐051330-­‐01-­‐	  0005	  
SMARTpool:	  ON-­‐TARGETplus	  Ptbp1	  siRNA	   Dharmacon	   L-­‐042865-­‐01-­‐	  0005	  
SMARTpool:	  ON-­‐TARGETplus	  Hnrnpu	  siRNA	   Dharmacon	   L-­‐051574-­‐01-­‐	  0005	  
SMARTpool:	  ON-­‐TARGETplus	  Myef2	  siRNA	   Dharmacon	   L-­‐058553-­‐01-­‐	  0005	  	  
SMARTpool:	  ON-­‐TARGETplus	  YY1	  siRNA	   Dharmacon	   L-­‐050273-­‐00-­‐0005	  
SMARTpool:	  ON-­‐TARGETplus	  Celf1	  siRNA	   Dharmacon	   L-­‐064577-­‐01-­‐0005	  
SMARTpool:	  ON-­‐TARGETplus	  Raly	  siRNA	   Dharmacon	   L-­‐044852-­‐02-­‐0005	  
SMARTpool:	  ON-­‐TARGETplus	  Hnrnpm	  siRNA	   Dharmacon	   L-­‐044465-­‐01-­‐0005	  
SMARTpool:	  ON-­‐TARGETplus	  Atrx	  siRNA	   Dharmacon	   L-­‐046292-­‐01-­‐0005	  
SMARTpool:	  ON-­‐TARGETplus	  Satb1	  siRNA	   Dharmacon	   L-­‐045547-­‐01-­‐0005	  
SMARTpool:	  ON-­‐TARGETplus	  Eed	  siRNA	   Dharmacon	   L-­‐049898-­‐00-­‐0005	  
SMARTpool:	  ON-­‐TARGETplus	  Srsf1	  siRNA	   Dharmacon	   L-­‐040886-­‐01-­‐0005	  
ON-­‐TARGETplus	  Non-­‐	  targeting	  Pool	   Dharmacon	   D-­‐001810-­‐10-­‐	  05	  
Silencer	  Select	  Pre-­‐Designed	  siRNA:	  Ncor2	   Ambion/Life	  Technologies	   Assay	  Id	  s74030	  
Silencer	  Select	  Pre-­‐Designed	  siRNA:	  Spen	   Ambion/Life	  Technologies	   Assay	  Id	  s80456	  	  
FlexiTube	  GeneSolution	  GS56381	  for	  Spen	   Qiagen	   GS56381	  
FlexiTube	  GeneSolution	  GS98386	  for	  Lbr	   Qiagen	   GS98386	  
FlexiTube	  GeneSolution	  GS51810	  for	  Hnrnpu	   Qiagen	   GS51810	  
FlexiTube	  GeneSolution	  GS20602	  for	  Ncor2	   Qiagen	   GS20602	  
GFP	  siRNA	  (1	  nmol)	   Qiagen	   SI04380467	  
	   	   	  
	   	   	  
	   	   	  
	  
Individual	  siRNA	  deconvoluted	  from	  the	  pool	  
Description	   	   Company	   Catalog	  number	  
SMARTpool:	  ON-­‐TARGETplus	  Spen	  siRNA	  Upgrade	   Dharmacon	   LU-­‐062019-­‐01-­‐0002	  
D1:	  CGAGAGGGAGAGACGAAUA	  
D2:	  CUAAAGAGCCGGAGCCGAA	  
D3:	  CCUAAAAUCACGUCGGUUA	  
D4:	  GGAAACACCUCAAGGCCGA	  
SMARTpool:	  ON-­‐TARGETplus	  Lbr	  siRNA	  Upgrade	   Dharmacon	   LU-­‐051330-­‐01-­‐0002	  
D1:	  UGUUGAAGCCGUUCGGAAA	  
D2:	  AUACAAAGAUGGCACCGAA	  
D3:	  AUAAACACAUAGACGACUU	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D4:	  GUACUAGUGAGGUUGGAUA	  
SMARTpool:	  ON-­‐TARGETplus	  Hdac3	  siRNA	  Upgrade	   Dharmacon	   LU-­‐043553-­‐02-­‐0002	  
D1:	  GGGAAUGUGUUGAAUAUGU	  
D2:	  CGGCAGACCUCCUGACGUA	  
D3:	  GCACCCGCAUCGAGAAUCA	  
D4:	  UAUAAGAAGAUGAUCGUCU	  
FlexiTube	  GeneSolution	  for	  Spen	   Qiagen	   GS56381	  
Q1:	  CAGGAGCATTTGATCGGACAA	  
Q2:	  CCCGAGCATCGTCACCACCAA	  
Q3:	  CAGGAAGACTAACAAGAGCAA	  
Q4:	  CACGAGGGAAGGTAACCCTAA	  
FlexiTube	  GeneSolution	  for	  Lbr	   Qiagen	   GS98386	  
Q1:	  CAGCCCAATATTGGTGTTATA	  
Q2:	  TACAATTCATTTAAAGTTAAA	  
Q3:	  AAAGTGCATTTGGAAATATAA	  
Q4:	  GAGGGAAATTCTGCAAGTTAA	  
FlexiTube	  GeneSolution	  for	  Hnrnpu	   Qiagen	   GS51810	  
Q1:	  CACAGTGTCTTGGCAAGTTTA	  
Q2:	  CACCAAGGATATTATTGAATA	  
Q3:	  ACGGGTATTCTCTGAAAGGAA	  
Q4:	  CAGTAAGACACTTATATACAA	  
FlexiTube	  GeneSolution	  for	  Ncor2	   Qiagen	   GS20602	  
Q1:	  CGCATTTGGAACCAAAGTCTA	  
Q2:	  CAGGCCTTATGACCTGTAGAA	  
Q3:	  CCGGAACGAGCCAGAATACAA	  
Q4:	  TACGATGAGAACCGGAAGAAA	  
Silencer	  Select	  Pre-­‐Designed	  siRNA:	  Ncor2	   Ambion/Life	  
Technologies	  
Assay	  Id	  s74030	  
Sense:	  CGUUCUCUGGGUUACCACAtt	  
Antisense:	  UGUGGUAACCCAGAGAACGga	  
	  
	  
	  
